Pharmafile Logo
Pharmafocus logo
Advanced Search

Vitae Pharmaceuticals

Showing 3 posts of 3 posts found.

Vitae Pharma soars on positive mid-stage trial results for psoriasis drug

March 17, 2016
Business Services, Research and Development, Sales and Marketing Vitae Pharmaceuticals, drug trial, psoriasis, research

Shares in Vitae Pharmaceuticals (Nasdaq: VTAE) nearly doubled in pre-market trading Thursday after the company reported mid-stage trials of its psoriasis …

News

Dr Karen Bernstein joins Ovid and Vitae boards

October 1, 2015
Medical Communications, Sales and Marketing Dr Karen Bernstein, Ovid Therapeutics, Vitae Pharmaceuticals

Ovid Therapeutics has announced the appointment of Karen Bernstein to the company’s Board of Directors. Dr Bernstein says: “I have …

Appointment

Boehringer and Vitae Pharma drug fails in mid-stage trial

July 1, 2015
Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes

A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …

News
The Gateway to Local Adoption Series

Latest content

Global coalition calls for stronger government action on COPD

September 18, 2026

Global health researchers call for more equitable partnerships

September 17, 2026

Liverpool launches £20m lab for infectious disease drug discovery

September 16, 2026

Circle Health Group expands into UK laboratory operations

September 15, 2026

FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

September 14, 2026